Sangamo Therapeutics
SGMO
#8626
Rank
ยฃ0.13 B
Marketcap
ยฃ0.42
Share price
6.05%
Change (1 day)
-56.37%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -ยฃ83.1 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ32.87 Million. In 2024 the company made an earning of -ยฃ72 Million, an increase over its 2023 earnings that were of -ยฃ87.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ83.1 Million15.41%
2024 -ยฃ72 Million-17.27%
2023 -ยฃ87.03 Million-40.88%
2022 -ยฃ0.15 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ94.75 Million23.17%
2019 -ยฃ76.93 Million36.33%
2018 -ยฃ56.43 Million36.89%
2017 -ยฃ41.22 Million-22.32%
2016 -ยฃ53.07 Million54.86%
2015 -ยฃ34.27 Million75.62%
2014 -ยฃ19.52 Million0.13%
2013 -ยฃ19.49 Million
2011 -ยฃ26.2 Million43.66%
2010 -ยฃ18.24 Million28.52%
2009 -ยฃ14.19 Million-23.55%
2008 -ยฃ18.56 Million2.45%
2007 -ยฃ18.12 Million19.5%
2006 -ยฃ15.16 Million50.78%
2005 -ยฃ10.06 Million75%
2004 -ยฃ5.75 Million-33.25%
2003 -ยฃ8.61 Million-62.27%
2002 -ยฃ22.82 Million102.82%
2001 -ยฃ11.25 Million23.21%
2000 -ยฃ9.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ23.69 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.02 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.39 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ0.55 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.22 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.88 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ95.3 M-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.49 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA